Harry Stylli

Over the course of his career, healthcare investor and entrepreneur Dr. Harry Stylli has provided executive leadership to numerous innovative companies. Dr. Harry Stylli currently serves as chairman of OncoCellMDx, a privately held diagnostic testing developer. Using technologies created internally and licensed through Harvard Medical School, the company has created non-invasive blood-based tests to evaluate a cancer’s grade and level of aggression..  Continue.

Latest News

The 10 Most Important Breakthroughs in Genetics

The 10 Most Important Breakthroughs in Genetics

Since the Human Genome Project, the field of genetics has expanded rapidly, promoting greater scientific understanding of the link between genes and disease. Let’s take a look at some of the most important discoveries in the field of genetics throughout history.   Charles Darwin publishes On the Origin of the Species (1859) Darwin established the… Continue Reading

Spotlight on the Bio4Comp Project

Spotlight on the Bio4Comp Project

Since the completion of the Human Genome Project at the dawn of the 21st century, significant advancements have been made in biocomputational technology. The role of personalized medicine is expected to increase as scientists gain a greater understanding of our DNA and the link between genetics and disease.The Bio4Comp research project is an EU initiative… Continue Reading